Monocyte count in schizophrenia and related disorders: a systematic review and meta-analysis

scientific article published on 17 March 2020

Monocyte count in schizophrenia and related disorders: a systematic review and meta-analysis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/NEU.2020.12
P698PubMed publication ID32178747

P50authorMario Gennaro MazzaQ87757510
P2093author name stringMassimo Clerici
Aurora Rossetti
Sara Lucchi
Ilaria Tagliabue
Martina Capellazzi
P2860cites workOperating characteristics of a rank correlation test for publication biasQ27860653
Measuring inconsistency in meta-analysesQ27860655
Postmortem evidence of cerebral inflammation in schizophrenia: a systematic reviewQ28077391
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesQ28131633
Association of schizophrenia and autoimmune diseases: linkage of Danish national registersQ28300105
Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effectsQ28657600
Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studiesQ33601896
The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R)Q33762930
Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysisQ34307827
Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychosesQ34855372
Is there a role for immune-to-brain communication in schizophrenia?Q36351021
Microglial activation and progressive brain changes in schizophreniaQ36546971
Developments in schizophrenia genetics: from linkage to microchips, deletions and duplicationsQ37832739
The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytesQ38033144
C-reactive protein levels in schizophrenia: a review and meta-analysisQ38083425
Autoimmunity, inflammation, and psychosis: a search for peripheral markersQ38167116
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric diseaseQ38203104
The neurobiology and treatment of first-episode schizophreniaQ38232366
Neuroimmune biomarkers in schizophreniaQ38240016
Role of T helper lymphokines in the immune-inflammatory pathophysiology of schizophrenia: Systematic review and meta-analysisQ38296243
Gray literature: An important resource in systematic reviewsQ38600485
Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future DirectionsQ38809444
A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder patients - a retrospective file reviewQ39394400
Chemokine gene variants in schizophreniaQ40892921
Correlation or coincidence between monocytosis and worsening of psychotic symptoms in veterans with schizophrenia?Q45331056
Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-ReviewQ47152736
Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort.Q47380198
Association of psychosis, affective disorders and diseases affecting the immune systemQ47574105
Blood cell count in antipsychotic-naive patients with non-affective psychosis.Q47652025
Resistin as an inflammatory marker in patients with schizophrenia treated with clozapineQ47931115
Antipsychotics influence Toll-like receptor (TLR) expression and its relationship with cognitive functions in schizophrenia.Q48387210
Altered levels of acute phase proteins in the plasma of patients with schizophreniaQ48515944
Elevated levels of C-reactive protein and IL-6 among the antipsychotic medicating schizophrenia patients of Siliguri, West Bengal, IndiaQ49717403
Total and differential white blood cell counts and hemodynamic parameters in first-episode psychosisQ49974448
Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patientsQ51000957
An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forcesQ51818315
Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluationQ51888144
Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant DataQ52589352
High neutrophil-lymphocyte ratio in schizophrenia independent of infectious and metabolic parameters.Q54237180
Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients.Q54419664
Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammationQ57821593
Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis studyQ60473570
Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: markers of vulnerability or disease?Q71735963
Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenicsQ73629060
Impaired monocyte activation in schizophreniaQ83690314
The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophreniaQ87054257
Microglia and schizophrenia: where next?Q87682786
Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysisQ90345862
Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosisQ91075282
P921main subjectschizophreniaQ41112
P304page(s)1-23
P577publication date2020-03-17
P1433published inActa NeuropsychiatricaQ4676734
P1476titleMonocyte count in schizophrenia and related disorders: a systematic review and meta-analysis

Search more.